Abstract

Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)

Author(s): Voudrie Mark A II, Allen D Brett

Issue: Jan/Feb 2010 - Pediatrics and Wellness

Page(s): 82-85

Download in electronic PDF format for $75
  • Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Page 1
  • Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Page 2
  • Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Page 3
  • Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Page 4

Abstract

Oseltamivir (Tamiflu) is widely prescribed to treat and prevent influenza virus A, influenza virus B, and H1N1 Flu. It is manufactured by Roche in 75- mg capsules. The need for other administration options for patients who cannot take capsules and cannot use suspending agents which contain alcohol, sorbitol, or preservatives has led to the compounding of oseltamivir into three suspending vehicles that do not contain these chemicals. All three contain neither alcohol nor sorbitol; the third also has no preservatives, a distinct advantage for special patient situations. The objective of this study was to determine the stability of oseltamivir in three different suspending agents: SyrSpend SF, Cherry Syrup, and SyrSpend SF (for reconstitution). The studied samples were compounded into 15-mg/mL suspensions and stored in low actinic plastic prescription bottles at temperatures between 2°C and 8°C. Triplicate samples were assayed at time intervals out to 30 days by a stability-indicating high-performance liqu

Related Keywords

  • oseltamivir phosphate
  • influenza
  • oral liquid preparations
  • children
  • stability
  • storage
  • alcohol
  • sorbitol
  • preservatives

Related Categories

  • EXCIPIENTS
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • INFECTIOUS DISEASE
  • STORAGE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2010
Pg. 82-85
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Author(s): Voudrie Mark A II, Allen D Brett
Jul/Aug 2018
Pg. 323
Oseltamivir Phosphate 15 mg/mL in SyrSpend SF
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 344-346
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Sep/Oct 2015
Pg. 420-427
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul
Nov/Dec 2018
Pg. 516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
May/Jun 2011
Pg. 255-258
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles
Author(s): Voudrie Mark A, Alexander Bridget, Allen D Brett
Mar/Apr 2007
Pg. 164-176
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations
Author(s): Ford Stephen M, Kloesel Lawson G, Grabenstein John D
May/Jun 2017
Pg. 240-241
Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil
Author(s): Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid
Jul/Aug 2018
Pg. 321
Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 510-512
Stability of Ursodiol in SyrSpend SF Cherry Flavored
Author(s): Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
May/Jun 2019
Pg. 231
Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 315
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2012
Pg. 347-349
Stability of Gabapentin in SyrSpend SF
Author(s): Sorenson Bridget, Voudrie Mark A II, Gehrig Dan
Jul/Aug 2020
Pg. 327-336
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Author(s): Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
Nov/Dec 2019
Pg. 487
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 336-338
Stability of Captopril in SyrSPend SF
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Nov/Dec 2019
Pg. 493
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 513-515
Stability of Propranolol Hydrochloride in SyrSpend SF
Author(s): Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
Nov/Dec 2008
Pg. 558-564
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Author(s): Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Jul/Aug 2021
Pg. 327
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Author(s): Allen Loyd V Jr